American Oriental Bioengineering (AOB) Misses Q2 EPS by 2c, Revenue Fell 30% Y/Y
Tweet Send to a Friend
American Oriental Bioengineering (NYSE: AOB) reported Q2 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
